Sean S Park

11PUBLICATIONS
115CO-AUTHORS
Predictive and prognostic markersRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 30, 2026
Early ctDNA Stratifies Survival in Locally Advanced and Oligometastatic Lung Cancer Treated with Radiotherapy.

|May 07, 2025
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial.

Jarey H Wang, Alexander D Sherry, Soha Bazyar

|Mar 14, 2025
Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trial.

Jacob J Orme, Henan Zhang, Prashanth Lingamaneni

|Jan 17, 2025
PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts.

Jack R Andrews, Yohan Kim, Edlira Horjeti

|Aug 23, 2024
Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer.

Pradeep S Chauhan, Irfan Alahi, Savar Sinha

|Nov 15, 2023
Salvage therapy expands highly cytotoxic and metabolically fit resilient CD8+ T cells via ME1 up-regulation.

Joanina K Gicobi, Zhiming Mao, Grace DeFranco

Pageof 2

Frequent Collaborators

6 joint publications

Jacob J Orme

5 joint publications

Aaron S Mansfield

5 joint publications

Haidong Dong

4 joint publications

Fabrice Lucien